Patents-Review.com
🔗 Permalink
Assignee profile:

CELLECTAR, INC.

City:

MADISON, Wisconsin

Country:

United States

Published Applications:

15

Last publication date:

2016-08-11

Patent Grants:

14

Last grant date:

2018-06-26

Top Inventors for applications by CELLECTAR, INC.

These are the the leading inventors for applications assigned to CELLECTAR, INC.:

Recent patent applications by CELLECTAR, INC.

CELLECTAR, INC. based in MADISON, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2016-08-11 ✅ Patent 10,004,818 granted on 2018-06-26
US20160228588A1
Human necessities

Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer

 #2 | 2015-04-02 ✅ Patent 9,550,002 granted on 2017-01-24
US20150093330A1
Human necessities

Phospholipid analogs as diapeutic agents and methods thereof

 #3 | 2015-02-12 ✅ Patent 9,616,140 granted on 2017-04-11
US20150044142A1
Human necessities

Fluorescent phospholipid ether compounds, compositions, and methods of use

 #4 | 2015-01-29 ✅ Patent 9,579,406 granted on 2017-02-28
US20150030538A1
Human necessities

Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof

 #5 | 2014-01-30 ✅ Patent 8,877,160 granted on 2014-11-04
US20140030187A1
Human necessities

Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof

 #6 | 2014-01-23 ✅ Patent 8,877,159 granted on 2014-11-04
US20140023587A1
Human necessities

Phospholipid analogs as diapeutic agents and methods thereof

 #7 | 2013-12-26 ✅ Patent 9,339,564 granted on 2016-05-17
US20130343991A1
Human necessities

Ether and alkyl phospholipid compounds for treating cancer and imaging and detection of cancer

 #8 | 2012-06-21
US20120156133A1
Human necessities

NON-RADIOACTIVE PHOSPHOLIPID COMPOUNDS, COMPOSITIONS, AND METHODS OF USE

 #9 | 2012-05-24 ✅ Patent 8,871,181 granted on 2014-10-28
US20120128596A1
Human necessities

Fluorescent phospholipid ether compounds, compositions, and methods of use

 #10 | 2010-10-12 ✅ Patent 7,811,548 granted on 2010-10-12
US12463970
-

Fluorescent phospholipid ether compounds and compositions

 #11 | 2009-01-15 ✅ Patent 8,022,235 granted on 2011-09-20
US20090018357A1
Chemistry; metallurgy

Compositions of phospholipid ether boronic acids and esters and methods for their synthesis and use

 #12 | 2008-12-18 ✅ Patent 7,893,286 granted on 2011-02-22
US20080312459A1
Chemistry; metallurgy

Method for the synthesis of phospholipid ethers

 #13 | 2007-01-25 ✅ Patent 8,540,968 granted on 2013-09-24
US20070020178A1
Human necessities

Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof

 #14 | 2006-10-12 ✅ Patent 7,632,644 granted on 2009-12-15
US20060228298A1
Chemistry; metallurgy

Imaging and selective retention of phospholipid ether analogs

 #15 | 2005-09-08 ✅ Patent 8,535,641 granted on 2013-09-17
US20050196339A1
Human necessities

Phospholipid analogs as diapeutic* agents and methods thereof

Also check out Cellectar, Inc.'s (Madison, United States) applicant profile with 7 patent applications submitted.

AssigneeID:

49838 ⎘